The month of November saw six different sectors represented among the 10 most actively traded stocks with the biggest volume increases. Almost half of the 10 most actively traded stocks were real estate plays. They comprised two REITs – AIMS AMP Capital Industrial REIT and Manulife US REIT, one Real Estate Developer – GSH Corporation, and one Real Estate Operating Company – Global Logistic Properties.
Output from Singapore’s semiconductors sector (accounting for 17% of total manufacturing activity) increased 41.7% YoY in October 2016, building on the 35.9% expansion seen in September. The global semiconductor industry also saw resurgent sales momentum.
The Singapore stock market has seen mixed returns across sectors post US-elections, with evidence of sectoral rotation to cyclical plays from less cyclical stocks. Singapore’s Consumer Staples Sector has remained relatively resilient despite its defensive nature, averaging a total return of 0.9% in the month-to-date, in line with STI’s 1.0%, but outperforming the MSCI AC Asia Pacific Consumer Staples Index’s -4.0%.
Post-US elections, the SGX S-REIT Index has corrected 4.5%, underperforming the flat performance of the benchmark Straits Times Index (STI), but in line with that of the MSCI World REIT Index, largely due to rising expectations of an interest rate hike by the Fed next month.
On Wednesday, trading volume of COSCO Corporation (Singapore) was almost triple its three month average volume, and trading volume of Yangzijiang Shipbuilding Holdings was more than double its three month average volume. On the close, the two stocks delivered respective session gains of 5.9% and 5.2%.
Singapore's three listed banks, DBS, OCBC and UOB averaged a marginal gain yesterday amidst declines in the broader markets. This was on the back of a 4.0% average gain last week, in contrast to the Bloomberg Asia Pacific Banks Index gain of 3.4%.
The unexpected election of Donald Trump as US President has sparked increased volatility and uncertainty in global markets this week. A Trump victory initially triggered a knee-jerk collapse in stock market futures and a surge in gold prices as investors fled to haven assets, but since then, global equity and commodity markets have registered mixed performances.
The three SGX-listed gold mining stocks have averaged 4.6% gain on Wednesday, ranging from +2.9% for Anchor Resources to 5.9% for Wilton Resources. All three SGX-listed gold mining stocks are at different stages of exploration and production and have all provided recent updates to their operations in the past fortnight. The SPDR® Gold Shares ETF gained 0.9% (1.5% in SGD) yesterday, bringing the one-month SGD equivalent total return to 4.8% and YTD gain to 19.2%.
The SGX All Healthcare Index has generated a 6.4% total return in the year-to-date, and maintains a dividend yield of 5.9%. This compares with the MSCI AC Asia Pacific Asia ex-Japan Health Care Index, which has declined 2.4% in Singapore dollar terms over the same period, and maintains a yield of 1.2%.
Three Consumer Staples stocks – Super Group, Japfa and SunMoon Food Company – and one Consumer Discretionary stock, Genting Singapore, were among the 10 biggest volume leaders last week.
These articles are provided by SGX My Gateway.
SGX's investor education portal with market, product and investment information and events. Sign up now at sgx.com/mygateway to receive our investment updates and economic calendar.
These articles are not intended for distribution to, or for use by or to be acted on by any person or entity located in any jurisdiction where such distribution, use or action would be contrary to applicable laws or regulations or would subject Singapore Exchange Limited (“SGX”) to any registration or licensing requirement. This document is not an offer or solicitation to buy or sell, nor financial advice or recommendation for any investment product. This document is for general circulation only. It does not address the specific investment objectives, financial situation or particular needs of any person. Advice should be sought from a financial adviser regarding the suitability of any investment product before investing or adopting any investment strategies. Use of and/or reliance on this document is entirely at the reader’s own risk. Further information on this investment product may be obtained from www.sgx.com. Investment products are subject to significant investment risks, including the possible loss of the principal amount invested. Past performance of investment products is not indicative of their future performance. Examples provided are for illustrative purposes only. While each of SGX and its affiliates (collectively, the “SGX Group Companies”) have taken reasonable care to ensure the accuracy and completeness of the information provided, each of the SGX Group Companies disclaims any and all guarantees, representations and warranties, expressed or implied, in relation to this document and shall not be responsible or liable (whether under contract, tort (including negligence) or otherwise) for any loss or damage of any kind (whether direct, indirect or consequential losses or other economic loss of any kind, including without limitation loss of profit, loss of reputation and loss of opportunity) suffered or incurred by any person due to any omission, error, inaccuracy, incompleteness, or otherwise, any reliance on such information, or arising from and/or in connection with this document. The information in this document may have been obtained via third party sources and which have not been independently verified by any SGX Group Company. No SGX Group Company endorses or shall be liable for the content of information provided by third parties. The SGX Group Companies may deal in investment products in the usual course of their business, and may be on the opposite side of any trades. SGX is an exempt financial adviser under the Financial Advisers Act (Cap. 110) of Singapore. The information in this document is subject to change without notice. This document shall not be reproduced, republished, uploaded, linked, posted, transmitted, adapted, copied, translated, modified, edited or otherwise displayed or distributed in any manner without SGX’s prior written consent.